Skip to content

Guardant Health GH Ratios & Valuation

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin256%+16.2pp252.4%+15.1pp248.7%+12.5pp244.1%239.7%
Operating margin-190.6%+82.1pp-207.9%+93.8pp-223.4%+118pp-248.8%+114pp-272.6%+118pp
Net margin-176.6%+86.5pp-190.3%+95.3pp-207%+105pp-236.8%+81.5pp-263.1%+78.6pp
Efficiency
Asset turnover2.4×+0.7×2.3×+0.7×2.2×+0.7×1.9×+0.6×1.7×+0.5×
Liquidity
Current ratio16.7×-4.7×16.2×-7.1×16×-9.1×18.7×-6.1×21.4×-4.0×
Per Share
Book value per share-$7.47-104%-$8.12-653%-$8.46-673%-$6.11-257%-$3.66-155%
Valuation
Market capitalization$39.37B+156%$32.51B+157%$23.02B+89.4%$18.05B+40.8%$15.39B+14.2%
Price / sales40.8×+19.4×36.4×+17.6×28×+8.5×23.4×+1.5×21.5×-3.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Guardant Health's profit margins?
Guardant Health (GH) runs a 64.9% gross margin and a -41.4% operating margin, with a -40.1% net margin.
Where do Guardant Health's ratios come from?
Every ratio is computed from Guardant Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.